A report is available on pharmaceutical expenditure and the burden of non-communicable diseases in Serbia. The topic appears to be related to healthcare, but its connection to a broader market forecast for the asia pacific region is unclear. The focus of the report itself seems to be specifically on serbia, while other information may pertain to a larger geographic area.